These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37845657)

  • 1. The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma.
    Zhang B; Han D; Yang L; He Y; Yang S; Wang H; Zhang X; Du Y; Xiong W; Ha H; Shang P
    BMC Cancer; 2023 Oct; 23(1):986. PubMed ID: 37845657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR.
    Luo L; Wei D; Pan Y; Wang QX; Feng JX; Yu B; Kang T; Luo J; Yang J; Gao S
    Cancer Commun (Lond); 2023 Jul; 43(7):808-833. PubMed ID: 37378422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma.
    Cai Z; Luo W; Wang H; Zhu R; Yuan Y; Zhan X; Xie M; Zhuang H; Chen H; Xu Y; Li X; Liu L; Xu G
    Cancer Sci; 2024 Jun; 115(6):1791-1807. PubMed ID: 38480904
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
    Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration.
    Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G
    Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.
    Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y
    Front Immunol; 2023; 14():1224904. PubMed ID: 37809090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD72, a new immune checkpoint molecule, is a novel prognostic biomarker for kidney renal clear cell carcinoma.
    Tian L; Wang Y; Zhang Z; Feng X; Xiao F; Zong M
    Eur J Med Res; 2023 Nov; 28(1):531. PubMed ID: 37980541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression.
    You MH; Jeon MJ; Kim SR; Lee WK; Cheng SY; Jang G; Kim TY; Kim WB; Shong YK; Kim WG
    Sci Rep; 2021 Jan; 11(1):2054. PubMed ID: 33479369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
    Qiu J; Wang Z; Xu Y; Zhao L; Zhang P; Gao H; Wang Q; Xia Q
    BMC Urol; 2023 Mar; 23(1):45. PubMed ID: 36978048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
    Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
    Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Reduced PTGER3 Expression with Prognosis and Immune Infiltration in Clear Cell Renal Carcinoma.
    Yang K; Hu B; Zhu G; Yuan D; Wang W; Su H; Liu H; Zhu J
    Arch Esp Urol; 2023 Jun; 76(4):270-282. PubMed ID: 37455526
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
    Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
    BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
    Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
    Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma.
    Fu Y; Piao C; Zhang Z; Zhu Y; Sun S; Bi J; Kong C; Ju M
    Urol Oncol; 2020 Sep; 38(9):740.e1-740.e9. PubMed ID: 32402768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.